Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation

August 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, pharma, signet chemical corporation

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation Pvt. Ltd. for cGMP Quaternary Ammonium Compounds for …
News
Press release
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, GSK, Sanofi, brexit, pharmafile, top 10

While average temperatures dropped to a comfortable 22 degrees, the past week has put the EMA in a sticky position …
News
allergan

Almirall picks up Allergan’s dermatology portfolio to for $650m

August 3, 2018 Medical Communications, Sales and Marketing Allergan, Almirall, dermatology, pharma

Allergan has sealed a deal to sell its dermatology portfolio, comprising five brands, to Spanish pharmaceutical firm Almirall for $650 …
News
usmarinetankinbaghdad

Lawsuit alleges pharma giants funded terror in Iraq

August 2, 2018 Business Services, Medical Communications, Sales and Marketing AstraZeneca, Iraq War, J&J, JJ, Litigation, Roche, corruption, terrorism

The United States Justice Department is investigating claims that major pharmaceutical and medical device companies were aware that supplies that …
News

Novartis hands over global rights for two oncology drugs to Shanghai’s Laekna

August 2, 2018 Sales and Marketing Cancer, Laekna, Novartis, oncology, pharma

Novartis has revealed that it has jettisoned two of its clinical stage oncology products along with exclusive global development and …
News
rowa_vmax

Biosimilars and generics saved NHS £324m last year

August 2, 2018 Medical Communications, Sales and Marketing Cancer, NHS, biosimilars, funding, generics

The NHS watchdog, NHS Improvement, has revealed that the British National Health Service saved £324 million last financial year by …
News
otsuka_web

Otsuka scores EU schizophrenia approval, but acute myeloid leukaemia drug flops at Phase 3

August 1, 2018 Research and Development, Sales and Marketing Astex, Otsuka, Rxulti, guadecitabine, pharma, schizophrenia

It’s bittersweet news for Otsuka as it emerges that the European Commission saw fit to approve its therapy Rxulti (brexpiprazole) …
News

Pfizer notches two EU approvals, including Herceptin biosimilar

August 1, 2018 Research and Development, Sales and Marketing Cancer, EMA, EU, Genetech, Herceptin, Pfizer, Trazimera, Xeljanz, biosimilar, breast cancer, pharma

Pfizer is patting itself on the back after securing two new approvals in Europe within 24 hours: Xeljanz (tofacitinib citrate) …
News
novartis_outside_1

Novartis migraine prevention drug scores EU approval

July 31, 2018 Manufacturing and Production, Sales and Marketing Aimovig, Europe, Novartis, migraine, pharma

Novartis is celebrating the news that its calcitonin gene-related peptide receptor (CGRP-R) pathway therapy Aimovig (erenumab) has been approved by …
News

Progenics’ Azedra becomes first FDA-approved treatment for adrenal tumours

July 31, 2018 Manufacturing and Production, Sales and Marketing Cancer, FDA, Progenics, adrenal cancer, pharma

The FDA has approved its first-ever drug for rare, unresectable tumours of the adrenal gland with its decision to authorise …
News
wockhardt_hospital_mumbai

Wockhardt launches $40m manufacturing plant in Dubai

July 30, 2018 Manufacturing and Production, Sales and Marketing Antibiotics, Dubai, India, Wockhardt, antibiotic resistance, pharma

Indian pharmaceutical firm Wockhardt has launched its first manufacturing facility in Dubai’s Jebel Ali Free Zone (Jafza). Costing $40 million, …
News
Medicines in an automated pharmacy

EU Commission grants market authorisation for Sandoz’ Humira biosimilar

July 30, 2018 Sales and Marketing FDA, Sandoz, approval, biosimilar, european commision

The European Commission has granted marketing authorisation to Sandoz’ biosimilar Hyrimoz for use in all indications, including rheumatoid arthritis, plaque …
News
john-milligan-thumbnail-300x300

Gilead’s CEO and Chairman to both step down before year’s end

July 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …
Appointment

Living with Behçet’s disease

July 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Behçet's disease, patient experience, pharma

Suzanne Morris speaks to Pharmafocus to discuss her life with Behçet’s disease, a rare condition characterised by the inflammation of …
Feature
White blood cells

CHMP recommend white blood cell growth stimulator biosimilar to EMA

July 30, 2018 Sales and Marketing Amgen, CHMP, EMA, Neulasta, biosimilar, chemotherapy, pegfilgrastim

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of two separate …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025